Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hausegger, K; Reinprecht, P; Kau, T; Igerc, I; Lind, P.
Clinical experience with a commercially available negative oral contrast medium in PET/CT.
Rofo. 2005; 177(6): 796-799.
Doi: 10.1055/s-2005-858197
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Hausegger Klaus
- Co-Autor*innen der Med Uni Graz
- Kau Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- To evaluate a commercially available negative oral contrast material for PET/CT. In a prospective series of 49 patients, Mukofalk, which is a vegetarian-based substance, was used as a negative oral contrast medium in whole body PET/CT studies. Mukofalk was administered during a time period of 1.5 hours before the examination. Quality of small bowl distension and eventual pathological tracer uptake in the intestine were evaluated. Distension of the small bowel was excellent or good in 41 (85 %) and poor in 8 (15 %) patients. Mild tracer uptake in the small bowel was observed in 5 patients (10.2 %) and moderate uptake in another 2 patients (4 %). In none of these patients did the F-18 FDG uptake interfere with image interpretation. Mukofalk can be used as a negative oral contrast medium in PET/CT studies.
- Find related publications in this database (using NLM MeSH Indexing)
- Administration, Oral -
- Aged -
- Contrast Media - administration & dosage
- Contrast Media - pharmacokinetics
- Humans -
- Intestine, Small - metabolism
- Male -
- Middle Aged -
- Positron-Emission Tomography - methods
- Prospective Studies -
- Time Factors -
- Tomography, X-Ray Computed - methods
- Find related publications in this database (Keywords)
- dual modality PET/CT
- oral contrast medium
- negative contrast medium